@ihu-infiny.bsky.social
IHU Infiny - Institut des Maladies Inflammatoires Chroniques de l’Intestin (MICI) 📍Bâtiment IRIS - Hôpitaux de Brabois - CHRU Nancy, Vandoeuvre-lès-Nancy 54547 ➡️ https://www.ihu-infiny.fr/
🔬Recap from our #WorldIBDDay conference with Djésia Arnone & Benoit Chassaing – hosted by IHU Infiny & @afacrohnrch.bsky.social Crohn RCH
🧴❤️Microplastics, cardiovascular risk & IBD
Read more → www.ihu-infiny.fr/en/news/worl...
#WorldIBDDay #IBD #Research #TranslationalScience
📢 [Abstract submission] Join us on Oct 15, 2025 for a full day dedicated to scientific research in #IBD and #inflammation — basic, translational & clinical.
🌍 Connect with researchers & clinicians from across disciplines.
👉Submit : www.ihu-infiny.fr/actualites/f...
#IBD #CallForPapers #Futures2025
[🔬 Conference – FR]💬 Better understand how environmental & systemic factors influence IBD (Inflammatory Bowel Disease).
📅 Fri, May 16 | 10:00–12:00
📍 IRIS Auditorium – Brabois Hospitals, Nancy
🔗 More info and free registration here: www.ihu-infiny.fr/agenda/confe...
5 questions pour Comprendre le projet de recherche POL-MICI de soutenu par @afacrohnrch.bsky.social
@ihu-infiny.bsky.social
💡This study highlights the impact of bacteria capable of penetrating the intestinal mucus on the development of chronic inflammation and metabolic disorders.
🔗 Study: www.tandfonline.com/doi/full/10....
🔬 #TuesdayReading
Congrats to @chassainglab.bsky.social , co-Scientific Director of IHU Infiny & Head of the Microbiota-Host Interactions team @institutpasteur.bsky.social, on his study in #GutMicrobes!
⬇️ 1/2
🔬 #TuesdayReading
Check out the March issue of @lancetgastrohep.bsky.social!
👋Congrats to Prof. Peyrin-Biroulet and the authors on their new study, highlighting the importance of achieving the right therapeutic balance for patients with inflammatory bowel disease (IBD)
⬇️
🔬 #TuesdayReading
Check out the March issue of @lancetgastrohep.bsky.social!
👋Congrats to Prof. Peyrin-Biroulet and the authors on their new study, highlighting the importance of achieving the right therapeutic balance for patients with inflammatory bowel disease (IBD)
⬇️
The March issue of The Lancet Gastroenterology & Hepatology is out now at www.thelancet.com/gastrohep!
Content includes: alcohol & cancer risk, colorectal cancer, inflammatory bowel disease, appendicitis, MASLD, viral hepatitis + more...
#MedSky #GastroSky #LiverSky #IDSky #HepSky
🔗 Study: gut.bmj.com/content/earl...
📢 Press: www.pasteur.fr/fr/espace-pr...
👏 Congratulations to @chassainglab.bsky.social & team!
#IBD #Research
3/3
🦠 The study shows how emulsifiers like CMC (E466) & P80 disrupt gut microbiota, altering bacteria & promoting chronic inflammation.
🚀 A key step in understanding IBD.
2/3⬇️
🔬 #TuesdayReading
Congrats to Benoît Chassaing, co-scientific director of IHU Infiny & head of the Microbiota-Host Interactions team @institutpasteur.bsky.social, on his study in #Gut!
1/3⬇️
[#JOB] 📢 Sharing this great opportunity to work with an inspiring team!
Ne manquez pas cette opportunité de travailler avec une équipe inspirante !
#apply #postulez
🗽IHU Infiny in NY! @chassainglab.bsky.social , Co-Director for basic research at Infiny & Head of the Microbiota-Host Interactions Unit at the @pasteur.fr, visited the Icahn School of Medicine at Mount Sinai, hosted by Prof. Saurabh Mehandru.
🚀 Stay tuned for exciting collaborations ahead.
👋 Hello Bluesky!
We're thrilled to join the conversation here! At IHU Infiny, our mission is to advance research and innovation to enhance the lives of IBD patients. Let's connect and exchange ideas!
➡️ Follow us on: linktr.ee/ihu_infiny
